China’s Innolife Bets On Heart Failure Drug With Novel Mechanism

 
• By Dexter Jie Yan
  
heart failure
Chinese biotech developing INL1 candidate for heart failure • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia